EW Filing
4Filing Date: Jul 7, 2026
Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001225208-26-006535open_in_new
Total Value$35.9K
Trades1
Insiders1
Transaction Details
Lippis Daniel J.
CVP, TAVR·Direct
Tax W/H · Dispose
Common Stock
Shares-377
Price$95.18
Total Value$35.9K
Shares Owned After40.03K
Transaction DateJul 7, 2026
Footnotes ▸
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Post-Transaction Holdings
Lippis Daniel J.
| Security | Shares | Change |
|---|---|---|
| Common Stock | 40.03K | -377 (-0.93%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-07
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Lippis Daniel J.
CIK: 0002004380
Role: Officer (CVP, TAVR)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-07 | Code: F (Payment of exercise/tax)
Shares: -377 | Price: $95.18
Total Value: $35,882.86
Shares Owned After: 40,033.9103 | Ownership: D (Direct)
Footnotes:
[F1] Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Footnotes (Complete Index) ---
F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-07-07)